Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Hans Grosse-Wilde
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Disorders
Concepts & Ideas
Genes & Molecular Sequences
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
41
Rebmann, Vera
26
Doxiadis, Ilias
25
Schaefer, Ulrich
25
Beelen, Dietrich
22
Ottinger, Hellmut
21
Lindemann, Monika
16
Ferencik, Stanislav
15
Kreuzfelder, Ernst
13
Roggendorf, Michael
10
Elmaagacli, Ahmet
9
Peceny, Rudolf
7
Pässler, M
6
Seeber, Siegfried
6
Witzke, Oliver
6
Trenschel, Rudolf
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Hans Grosse-Wilde (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rebmann Vera; Bartsch Diana; Wunsch Andreas; Möllenbeck Petra; Golda Thomas; Viebahn Richard; Grosse-Wilde Hans
Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Human immunology 2009;70(12):995-9.
-
2009: Nückel Holger; Switala Magdalena; Collins Crista H; Sellmann Ludger; Grosse-Wilde Hans; Dührsen Ulrich; Rebmann Vera
High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
Clinical immunology (Orlando, Fla.) 2009;131(3):472-80.
-
2009: Schumann Alexandra; Lindemann Monika; Valentin-Gamazo Camino; Lu Mengji; Elmaagacli Ahmet; Dahmen Uta; Knop Dietmar; Broelsch Christoph E; Grosse-Wilde Hans; Roggendorf Michael; Fiedler Melanie
Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients.
Transplantation 2009;87(1):103-11.
-
2009: Lindemann Monika; Dioury Youness; Beckebaum Susanne; Cicinnati Vito R; Gerken Guido; Broelsch Christoph E; Wrighton-Smith Peter; Grosse-Wilde Hans
Diagnosis of tuberculosis infection in patients awaiting liver transplantation.
Human immunology 2009;70(1):24-8.
-
2009: Stark Klaus; Rovenský Jozef; Blazicková Stanislava; Grosse-Wilde Hans; Ferencik Stanislav; Hengstenberg Christian; Straub Rainer H
Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls.
Arthritis research & therapy 2009;11(3):R70.
-
2008: Schütt Philipp; Rebmann Vera; Brandhorst Dieter; Wiefelspütz Johannes; Ebeling Peter; Opalka Bertram; Seeber Siegfried; Nowrousian Mohammad R; Moritz Thomas; Grosse-Wilde Hans
The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Human immunology 2008;69(2):79-87.
-
2007: Rebmann Vera; Wagner Stefan; Grosse-Wilde Hans
HLA-G expression in malignant melanoma.
Seminars in cancer biology 2007;17(6):422-9.
-
2007: Rebmann Vera; Nückel Holger; Dührsen Ulrich; Grosse-Wilde Hans
HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Seminars in cancer biology 2007;17(6):430-5.
-
2007: Schumann A; Fiedler M; Dahmen U; Grosse-Wilde H; Roggendorf M; Lindemann M
Cellular and humoral immune response to a third generation hepatitis B vaccine.
Journal of viral hepatitis 2007;14(8):592-8.
-
2007: Heinemann Falko M; Roth Ioana; Rebmann Vera; Arnold Marie-Luise; Witzke Oliver; Wilde Benjamin; Spriewald Bernd M; Grosse-Wilde Hans
Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
Human immunology 2007;68(6):500-6.
-
2007: Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella E D; Grosse-Wilde H
Quantification and identification of soluble HLA-G isoforms.
Tissue antigens 2007;69 Suppl 1():143-9.
-
2007: Rebmann Vera; Switala Magdalena; Eue Ines; Schwahn Eva; Merzenich Markus; Grosse-Wilde Hans
Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos.
Human immunology 2007;68(4):251-8.
-
2007: Rebmann Vera; Schütt Philipp; Brandhorst Dieter; Opalka Bertram; Moritz Thomas; Nowrousian Mohammad Reza; Grosse-Wilde Hans
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
Clinical immunology (Orlando, Fla.) 2007;123(1):114-20.
-
2007: Heinemann Falko M; Rebmann Vera; Witzke Oliver; Philipp Thomas; Broelsch Christoph E; Grosse-Wilde Hans
Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation.
Transplantation 2007;83(6):706-11.
-
2007: Fischer Johannes C; Ottinger Hellmut; Ferencik Stanislav; Sribar Martina; Punzel Michael; Beelen Dietrich W; Schwan M Alexander; Grosse-Wilde Hans; Wernet Peter; Uhrberg Markus
Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(6):3918-23.
-
2006: Lindemann Monika; Ottinger Hellmut D; Elmaagacli Ahmet H; Trenschel Rudolf; Rebmann Vera; Beelen Dietrich W; Grosse-Wilde Hans
Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
Experimental hematology 2006;34(12):1753-8.
-
2006: Cicinnati Vito R; Zhang Xia; Yu Zhengya; Ferencik Stanislav; Schmitz Klaus J; Dworacki Grzegorz; Kaczmarek Elzbieta; Oldhafer Karl; Frilling Andrea; Baba Hideo A; Schmid Kurt W; Grosse-Wilde Hans; Broelsch Christoph E; DeLeo Albert B; Gerken Guido; Beckebaum Susanne
Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2006;119(12):2851-60.
-
2006: Kumar Manoj; Putzki Norman; Limmroth Volker; Remus Ralph; Lindemann Monika; Knop Dietmar; Mueller Norbert; Hardt Cornelia; Kreuzfelder Ernst; Grosse-Wilde Hans
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
Journal of neuroimmunology 2006;180(1-2):178-84.
-
2006: Lindemann Monika; Witzke Oliver; Lütkes Peter; Fiedler Melanie; Kreuzfelder Ernst; Philipp Thomas; Roggendorf Michael; Grosse-Wilde Hans
ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.
Clinical immunology (Orlando, Fla.) 2006;120(3):342-8.
-
2006: Schütt Philipp; Brandhorst Dieter; Stellberg Werner; Poser Miriam; Ebeling Peter; Müller Siemke; Buttkereit Ulrike; Opalka Bertram; Lindemann Monika; Grosse-Wilde Hans; Seeber Siegfried; Moritz Thomas; Nowrousian Mohammad R
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
Leukemia & lymphoma 2006;47(8):1570-82.
-
2006: Verbruggen Leon A; Rebmann Vera; Demanet Christian; De Cock Seija; Grosse-Wilde Hans
Soluble HLA-G in rheumatoid arthritis.
Human immunology 2006;67(8):561-7.
-
2006: Zou Yizhou; Heinemann Falko M; Grosse-Wilde Hans; Sireci Guido; Wang Zhengnan; Lavingia Bhavna; Stastny Peter
Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.
Human immunology 2006;67(3):230-7.
-
2006: Hardt C; Ferencik S; Tak R; Hoogerbrugge P M; Wagner V; Grosse-Wilde H
Sequence-based typing reveals a novel DLA-88 allele, DLA-88*04501, in a beagle family.
Tissue antigens 2006;67(2):163-5.
-
2006: Elmaagacli Ahmet H; Koldehoff Michael; Hindahl Heidrun; Steckel Nina K; Trenschel Rudolf; Peceny Rudolf; Ottinger Hellmut; Rath Peter-Michael; Ross Rudolf Stefan; Roggendorf Michael; Grosse-Wilde Hans; Beelen Dietrich W
Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Transplantation 2006;81(2):247-54.
-
2006: Heinemann Falko M; Roth Ioana; Rebmann Vera; Arnold Marie-Luise; Spriewald Bernd M; Grosse-Wilde Hans
Characterization of anti-HLA antibodies eluted from explanted renal allografts.
Clinical transplants 2006;():371-8.
-
2005: Rebmann Vera; Lemaoult Joël; Rouas-Freiss Nathalie; Carosella Edgardo D; Grosse-Wilde Hans
Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Human immunology 2005;66(8):853-63.
-
2005: Elmaagacli Ahmet H; Ottinger Hellmut; Koldehoff Michael; Peceny Rudolf; Steckel Nina K; Trenschel Rudolf; Biersack Harald; Grosse-Wilde Hans; Beelen Dietrich W
Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor.
Transplantation 2005;79(12):1741-7.
-
2005: Schütt Philipp; Buttkereit Ulrike; Brandhorst Dieter; Lindemann Monika; Schmiedl Sven; Grosse-Wilde Hans; Seeber Siegfried; Nowrousian Mohammad Resa; Opalka Bertram; Moritz Thomas
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Cancer immunology, immunotherapy : CII 2005;54(5):506-12.
-
2005: Lindemann M; Schuett P; Moritz T; Ottinger H D; Opalka B; Seeber S; Nowrousian M R; Grosse-Wilde H
Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(3):490-2.
-
2005: Beelen Dietrich W; Ottinger Hellmut D; Ferencik Stanislav; Elmaagacli Ahmet H; Peceny Rudolf; Trenschel Rudolf; Grosse-Wilde Hans
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.
Blood 2005;105(6):2594-600.
-
2005: Lindemann Monika; Grosse-Wilde Hans; Ottinger Hellmut D; Peceny Rudolf; Beelen Dietrich W
G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients.
Transplantation 2005;79(3):377-8.
-
2005: Nückel Holger; Rebmann Vera; Dürig Jan; Dührsen Ulrich; Grosse-Wilde Hans
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
Blood 2005;105(4):1694-8.
-
2004: Lindemann Monika; Rebmann Vera; Ottinger Hellmut D; Schmolke Keiko; Kreuzfelder Ernst; Grosse-Wilde Hans
rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
Experimental hematology 2004;32(11):1103-9.
-
2004: Beckebaum Susanne; Zhang Xia; Chen Xiao; Yu Zhengya; Frilling Andrea; Dworacki Grzegorz; Grosse-Wilde Hans; Broelsch Christoph Erich; Gerken Guido; Cicinnati Vito R
Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7260-9.
-
2004: Ugurel Selma; Lindemann Monika; Schadendorf Dirk; Grosse-Wilde Hans
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?
Cancer immunology, immunotherapy : CII 2004;53(11):1051.
-
2004: Lindemann Monika; Witzke Oliver; Winterhagen Toni; Ross Birgit; Kreuzfelder Ernst; Reinhardt Walter; Roggendorf Michael; Mann Klaus; Philipp Thomas; Grosse-Wilde Hans
T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations.
AIDS (London, England) 2004;18(15):2001-7.
-
2004: Ottinger H D; Ferencik S; Beelen D W; Lindemann M; Peceny R; Elmaagacli A H; Grosse-Wilde H
Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.
Transplantation 2004;78(7):1077-80.
-
2004: Witzke Oliver; Patschan Daniel; Dürig Jan; Lindemann Monika; Wenzel Rene R; Philipp Thomas; Grosse-Wilde Hans; Kribben Andreas
A patient without monocytes who had pulmonary renal syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(3):556-8.
-
2004: Heinemann Falko M; Ferencik Stanislav; Ottinger Hellmut D; Beelen Dietrich W; Grosse-Wilde Hans
Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors.
Transplantation 2004;77(7):1103-6.
-
2004: Heiligenhaus A; Rebmann V; Neubert A; Plewa S; Ferencik S; Vögeler U; Steuhl K-P; Grosse-Wilde H
Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis.
Tissue antigens 2004;63(4):369-75.
-
2003: Rebmann V; Ronin-Walknowska E; Sipak-Szmigiel O; Miklaszewicz A; Czajkowska E; Grosse-Wilde H
Soluble HLA-DR and soluble CD95 ligand levels in pregnant women with antiphospholipid syndromes.
Tissue antigens 2003;62(6):536-41.
-
2003: Mueller Anke; Kreuzfelder Ernst; Nyadu Baerbel; Lindemann Monika; Rebmannn Vera; Majetschak Matthias; Obertacke Udo; Schade Ulrich F; Nast-Kolb Dieter; Grosse-Wilde Hans
Human leukocyte antigen-DR expression in peripheral blood mononuclear cells from healthy donors influenced by the sera of injured patients prone to severe sepsis.
Intensive care medicine 2003;29(12):2285-90.
-
2003: Rebmann Vera; Busemann Annika; Lindemann Monica; Grosse-Wilde Hans
Detection of HLA-G5 secreting cells.
Human immunology 2003;64(11):1017-24.
-
2003: Rebmann Vera; Regel Jens; Stolke Dietmar; Grosse-Wilde Hans
Secretion of sHLA-G molecules in malignancies.
Seminars in cancer biology 2003;13(5):371-7.
-
2003: Singer Gad; Rebmann Vera; Chen Yu-Chi; Liu Hsu-Tai; Ali Syed Z; Reinsberg Jochen; McMaster Michael T; Pfeiffer Kerstin; Chan Daniel W; Wardelmann Eva; Grosse-Wilde Hans; Cheng Chih-Chien; Kurman Robert J; Shih Ie-Ming
HLA-G is a potential tumor marker in malignant ascites.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4460-4.
-
2003: Beckebaum Susanne; Cicinnati Vito R; Zhang Xia; Ferencik Stanislav; Frilling Andrea; Grosse-Wilde Hans; Broelsch Christoph Erich; Gerken Guido
Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.
Immunology 2003;109(4):487-95.
-
2003: Ottinger Hellmut D; Ferencik Stanislav; Beelen Dietrich W; Lindemann Monika; Peceny Rudolf; Elmaagacli Ahmed H; Husing Johannes; Grosse-Wilde Hans
Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors.
Blood 2003;102(3):1131-7.
-
2003: Steinborn A; Rebmann V; Scharf A; Sohn C; Grosse-Wilde H
Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G.
Journal of clinical immunology 2003;23(4):307-14.
-
2003: Bukur Jürgen; Rebmann Vera; Grosse-Wilde Hans; Luboldt Hans; Ruebben Herbert; Drexler Ingo; Sutter Gerd; Huber Christoph; Seliger Barbara
Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Cancer research 2003;63(14):4107-11.
-
2003: Anastassiou Gerasimos; Rebmann Vera; Wagner Stephan; Bornfeld Norbert; Grosse-Wilde Hans
Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
Investigative ophthalmology & visual science 2003;44(5):2016-9.
-
2003: Zhou J H; Ferencik S; Rebmann V; Yang D L; Lu M; Roggendorf M; Grosse-Wilde H
Molecular genetic and biochemical analysis of woodchuck (Marmota monax) MHC class I polymorphism.
Tissue antigens 2003;61(3):240-8.
-
2003: Lindemann Monika; Barsegian Vahé; Runde Volker; Fiedler Melanie; Heermann Klaus-Hinrich; Schaefer Ulrich W; Roggendorf Michael; Grosse-Wilde Hans
Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation.
Transplantation 2003;75(6):833-8.
-
2003: Kröger K; Lindemann M; Kreuzfelder E; Bröcker M; Santosa F; Grosse-Wilde H
Effect of atorvastatin and clopidogrel on cellular immune function.
Prostaglandins, leukotrienes, and essential fatty acids 2003;68(3):251-5.
-
2003: Steinborn Andrea; Rebmann Vera; Scharf Alexander; Sohn Christof; Grosse-Wilde Hans
Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy.
American journal of obstetrics and gynecology 2003;188(2):473-9.
-
2003: Schmidt Stephan; Marrosu Giovanna Maria; Kölsch Heike; Haase Claus G; Ferenczik Stanislav; Sokolowski Piotr; Köhler Wolfgang; Schmidt Martina; Papassotiropoulos Andreas; Heun Reinhard; Grosse-Wilde Hans; Klockgether Thomas
Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy.
Journal of neuroimmunology 2003;135(1-2):148-53.
-
2003: Elmaagacli Ahmet H; Peceny Rudolf; Steckel Nina; Trenschel Rudolf; Ottinger Hellmut; Grosse-Wilde Hans; Schaefer Ulrich W; Beelen Dietrich W
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Blood 2003;101(2):446-53.
-
2002: Solier Corinne; Aguerre-Girr Maryse; Lenfant Françoise; Campan Agnès; Berrebi Alain; Rebmann Vera; Grosse-Wilde Hans; Le Bouteiller Philippe
Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.
European journal of immunology 2002;32(12):3576-86.
-
2002: Verbruggen Leon A; Versaen Hendrik; Rebmann Vera; Duquet William; De Cock Seija; Grosse-Wilde Hans; Demanet Christian
Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis.
Human immunology 2002;63(9):758-64.
-
2002: Rebmann Vera; Ugurel Selma; Tilgen Wolfgang; Reinhold Uwe; Grosse-Wilde Hans
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients.
International journal of cancer. Journal international du cancer 2002;100(5):580-5.
-
2002: Lindemann Monika; Barsegian Vahé; Siffert Winfried; Ferencik Stanislav; Roggendorf Michael; Grosse-Wilde Hans
Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.
Virology 2002;297(2):245-52.
-
2002: Ottinger Hellmut D; Rebmann Vera; Pfeiffer Kerstin A; Beelen Dietrich W; Kremens Bernhard; Runde Volker; Schaefer Ulrich W; Grosse-Wilde Hans
Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation.
Transplantation 2002;73(8):1280-5.
-
2002: Elmaagacli Ahmet H; Basoglu Semiha; Peceny Rudolf; Trenschel Rudolf; Ottinger Hellmut; Lollert Andre; Runde Volker; Grosse-Wilde Hans; Beelen Dietrich W; Schaefer Ulrich W
Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
Blood 2002;99(4):1130-5.
-
2002: Kremens B; Basu O; Peceny R; Grosse-Wilde H; Schaefer U W; Havers W
Allogeneic CD34+ -selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases.
Bone marrow transplantation 2002;29(1):9-13.
-
2001: Kremmer S; Kreuzfelder E; Klein R; Bontke N; Henneberg-Quester K B; Steuhl K P; Grosse-Wilde H
Antiphosphatidylserine antibodies are elevated in normal tension glaucoma.
Clinical and experimental immunology 2001;125(2):211-5.
-
2001: Kröger K; Kreuzfelder E; Moser C; Santosa F; Buss C; Grosse-Wilde H
Thrombangitis obliterans: leucocyte subpopulations and circulating immune complexes.
VASA. Zeitschrift für Gefässkrankheiten. Journal for vascular diseases 2001;30(3):189-94.
-
2001: Lindemann M; Virchow S; Ramann F; Barsegian V; Kreuzfelder E; Siffert W; Müller N; Grosse-Wilde H
The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response.
FEBS letters 2001;495(1-2):82-6.
-
2001: Maschke J; Menne S; Jacob J R; Kreuzfelder E; Tennant B C; Roggendorf M; Grosse-Wilde H
Thymidine utilization abnormality in proliferating lymphocytes and hepatocytes of the woodchuck.
Veterinary immunology and immunopathology 2001;78(3-4):279-96.
-
2001: Kremens B; Basu O; Grosse-Wilde H; Sauerwein W; Schaefer U W; Havers W
Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia.
Bone marrow transplantation 2001;27(1):111-3.
-
2001: Rebmann V; van der Ven K; Pässler M; Pfeiffer K; Krebs D; Grosse-Wilde H
Association of soluble HLA-G plasma levels with HLA-G alleles.
Tissue antigens 2001;57(1):15-21.
-
2001: Lewandrowski K U; Rebmann V; Pässler M; Schollmeier G; Ekkernkamp A; Grosse-Wilde H; Tomford W W
Immune response to perforated and partially demineralized bone allografts.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2001;6(6):545-55.
-
2000: Verbruggen L A; Dumarey N; Van de Velde H; Rebmann V; Flament J; Van Wayenberge C; Grosse-Wilde H; Demanet C
Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes.
Tissue antigens 2000;56(5):436-40.
-
2000: Ottinger H D; Müller C; Schmitz N; Kubanek B; Arnold R; Ebell W; Eberhard H P; Ehninger G; Fronz U; Goldmann S; Grosse-Wilde H; Havers W; Klingebiel T; Kolb H J; Seeber S; Schaefer U W; Baldomero H; Gratwohl A
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
-
2000: Pfeiffer K A; Rebmann V; Pässler M; van der Ven K; van der Ven H; Krebs D; Grosse-Wilde H
Soluble HLA levels in early pregnancy after in vitro fertilization.
Human immunology 2000;61(6):559-64.
-
1999: Ditschkowski M; Kreuzfelder E; Majetschak M; Obertacke U; Schade U F; Grosse-Wilde H
Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury.
The European journal of surgery = Acta chirurgica 1999;165(12):1129-33.
-
1999: Rebmann V; Pässler M; Erhard J; Lange R; Eigler F W; Grosse-Wilde H
Monitoring of soluble HLA class I size variants after liver transplantation.
Human immunology 1999;60(5):424-9.
-
1999: Ditschkowski M; Kreuzfelder E; Rebmann V; Ferencik S; Majetschak M; Schmid E N; Obertacke U; Hirche H; Schade U F; Grosse-Wilde H
HLA-DR expression and soluble HLA-DR levels in septic patients after trauma.
Annals of surgery 1999;229(2):246-54.
-
1999: Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Tissue antigens 1999;53(1):14-22.
-
1998: Witzke O; Winterhagen T; Reinhardt W; Heemann U; Grosse-Wilde H; Kreuzfelder E; Roggendorf M; Philipp T
Comparison between subcutaneous and intravenous interleukin-2 treatment in HIV disease.
Journal of internal medicine 1998;244(3):235-40.
-
1998: Menne S; Maschke J; Lu M; Grosse-Wilde H; Roggendorf M
T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.
Journal of virology 1998;72(7):6083-91.
-
1998: Kasimir-Bauer S; Ottinger H; Wuttke M; Stellberg W; Grosse-Wilde H; Seeber S; Scheulen M E
Chronic myelogenous leukemia: effect of interferon-alpha treatment on phagocytic activity and capacity of circulating neutrophils.
Leukemia research 1998;22(2):115-7.
-
1997: Beelen D W; Ottinger H D; Elmaagacli A; Scheulen B; Basu O; Kremens B; Havers W; Grosse-Wilde H; Schaefer U W
Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.
Blood 1997;90(12):4725-35.
-
1997: Ottinger H D; Albert E; Arnold R; Beelen D W; Blasczyk R; Bunjes D; Burdach S; Ebell W; Ehninger G; Einsele H; Enczmann J; Fauser A; Friedrich W; Finke J; Göbel U; Goldmann S F; Gramatzki M; Helbig W; Kanz L; Klingebiel T; Kolb H J; Kühnl P; Löliger C; Müller C R; Grosse-Wilde H
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1997;20(2):101-5.
-
1997: Gallagher G; Lindemann M; Oh H H; Ferencik S; Walz M K; Schmitz A; Richards S; Eskdale J; Field M; Grosse-Wilde H
Association of the TNFa2 microsatellite allele with the presence of colorectal cancer.
Tissue antigens 1997;50(1):47-51.
-
1997: Rebmann V; Dornmair K; Grosse-Wilde H
Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR.
Tissue antigens 1997;49(5):438-42.
-
1997: Menne S; Maschke J; Tolle T; Kreuzfelder E; Grosse-Wilde H; Roggendorf M
Determination of peripheral blood mononuclear cell responses to mitogens and woodchuck hepatitis virus core antigen in woodchucks by 5-bromo-2'-deoxyuridine or 2[3H]adenine incorporation.
Archives of virology 1997;142(3):511-21.
-
1996: Ottinger H D; Beelen D W; Scheulen B; Schaefer U W; Grosse-Wilde H
Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow.
Blood 1996;88(7):2775-9.
-
1996: Ottinger H; Beelen D; Sayer H; Schaefer U W; Grosse-Wilde H
Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: the experience at the University Hospital of Essen, Germany.
British journal of haematology 1996;92(4):913-21.
-
1996: Kreuzfelder E; Menne S; Ferencik S; Roggendorf M; Grosse-Wilde H
Assessment of peripheral blood mononuclear cell proliferation by [2-3H]adenine uptake in the woodchuck model.
Clinical immunology and immunopathology 1996;78(3):223-7.
-
1995: Lorenz A; Blasczyk R; Kuhn U; Venjakob U; Mendonca M; Grosse-Wilde H
Strong association between the responder status of the FC gamma II receptor and recurrent spontaneous abortion.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(5):397-401.
-
1995: Ottinger H; Schulze-Rath R; Schmitz A; Grosse-Wilde H
Progress of unrelated bone marrow donor search at the University Hospital of Essen (1991-1994).
Annals of hematology 1995;71(2):71-5.
-
1995: Kreuzfelder E; Quabeck K; Braun M; Weber W; Westhoff U; Schaefer U W; Bruch J; Costabel U; Grosse-Wilde H
Association of increased bronchoalveolar lavage fluid albumin and serum beta 2-microglobulin with pulmonary complications after allogeneic bone marrow transplantation.
Bone marrow transplantation 1995;16(2):249-52.
-
1995: Kubens B S; Krumbacher K; Grosse-Wilde H
Biochemical definition of DLA-A and DLA-B gene products by one-dimensional isoelectric focusing and immunoblotting.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(2):199-207.
-
1995: Westhoff U; Grosse-Wilde H
Soluble HLA class I and class II concentrations in factor VIII and PCC preparations.
Vox sanguinis 1995;68(2):73-6.
-
1995: Rebmann V; Kubens B S; Ferencik S; Grosse-Wilde H
Biochemical analysis of HLA-DP gene products by isoelectric focusing and comparison with cellular and molecular genetic typing results.
Experimental and clinical immunogenetics 1995;12(1):36-47.
-
1995: Pfeiffer K; Vögeler U; Albrecht K H; Eigler F W; Buchholz B; Grosse-Wilde H
HLA-DP antibodies in patients awaiting renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1995;8(3):180-4.
-
1994: Kubens B S; Pässler M; Grosse-Wilde H
Detection efficacy of soluble HLA-A, B antigens using 1D-IEF.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1994;21(6):469-77.
-
1994: Kubens B S; Pässler M; Grosse-Wilde H
Segregation study of the soluble 39-kD HLA class I heavy chain.
Human immunology 1994;40(3):247-52.
-
1994: Hillebrand K; Moritz T; Westhoff U; Niederle N; Grosse-Wilde H
Soluble HLA class I and beta-2-microglobulin plasma concentrations during interferon treatment of chronic myelogenous leukemia.
Vox sanguinis 1994;67(3):310-4.
-
1994: Ottinger H; Grosse-Wilde M; Schmitz A; Grosse-Wilde H
Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs.
Bone marrow transplantation 1994;14 Suppl 4():S34-8.
-
1993: Kremens B; Gomolka M; Ottinger H; Grosse-Wilde H; Schaefer U W; Epplen J T
Rapid detection of engraftment using T cell receptor gene polymorphism after allogeneic bone marrow transplantation in an alloimmunized child with severe aplastic anemia.
Bone marrow transplantation 1993;12(6):661-4.
-
1993: Ferencik S; Grosse-Wilde H
A simple photometric detection method for HLA-DRB1 specific PCR-SSP products.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1993;20(2):123-5.
-
1993: Blasczyk R; Westhoff U; Grosse-Wilde H
Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations.
Lancet 1993;341(8848):789-90.
-
1992: Ferencik S; Lindemann M; Horsthemke B; Grosse-Wilde H
A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1992;19(6):425-30.
-
1992: Strumberg D; Hauffa B P; Horsthemke B; Grosse-Wilde H
Molecular detection of genetic defects in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a study of 27 families.
European journal of pediatrics 1992;151(11):821-6.
-
1992: Grosse-Wilde H; Ferrara G B
European Collection for Biomedical Research.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1992;19(4):179-251.
-
1992: Grosse-Wilde H; Blasczyk R; Westhoff U
Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations.
Tissue antigens 1992;39(2):74-7.
-
1992: Rebmann V; Doxiadis I; Kubens B S; Grosse-Wilde H
Quantitation of the human component C4: definition of C4 Q0 alleles and C4A duplications.
Vox sanguinis 1992;62(2):117-23.
-
1991: Aulitzky W E; Grosse-Wilde H; Westhoff U; Tilg H; Aulitzky W; Gastl G; Herold M; Huber C
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).
Clinical and experimental immunology 1991;86(2):236-9.
-
1991: Kubens B S; Ferencik S; Grosse-Wilde H
An HLA-A/C,B recombination detected by one-dimensional isoelectric focusing gel electrophoresis.
Tissue antigens 1991;38(2):92-4.
-
1991: Kuhn U; Blasczyk R; Hojnacki B; Vögeler U; Luboldt W; Passarge E; Fischer W M; Grosse-Wilde H
Fc receptor blocking antibodies after active immunization for the treatment of recurrent spontaneous abortion.
Journal of reproductive immunology 1991;20(2):141-51.
-
1991: Beelen D W; Quabeck K; Mahmoud H K; Sayer H G; Kraft J; Graeven U; Grosse-Wilde H; Quast U; Schaefer U W
[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation]
Deutsche medizinische Wochenschrift (1946) 1991;116(11):401-10.
-
1991: Krumbacher K; Happel M; Grosse-Wilde H
Recognition of monocyte-associated antigens in the dog.
Tissue antigens 1991;37(1):21-5.
-
1991: Beelen D W; Grosse-Wilde H; Ryschka U; Quabeck K; Sayer H G; Graeven U; Schaefer U W
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptor.
Cancer immunology, immunotherapy : CII 1991;34(2):97-102.
-
1991: Westhoff U; Thinnes F P; Götz H; Grosse-Wilde H
Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay.
Vox sanguinis 1991;61(2):106-10.
-
1990: Blasczyk R; Kuhn U; Luboldt W; Passarge E; Fischer W M; Grosse-Wilde H
Further characterization of the EAI factor induced by alloimmunization for treatment of recurrent abortion.
Immunology letters 1990;26(2):115-9.
-
1990: Beelen D W; Quabeck K; Kaiser B; Wiefelspütz J; Scheulen M E; Graeven U; Grosse-Wilde H; Sayer H G; Schaefer U W
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1990;50(3):421-7.
-
1990: Knop J; Bonsmann G; Kind P; Doxiadis I; Vögeler U; Doxiadis G; Goerz G; Grosse-Wilde H
Antigens of the major histocompatibility complex in patients with chronic discoid lupus erythematosus.
The British journal of dermatology 1990;122(6):723-8.
-
1990: Teichner M; Krumbacher K; Doxiadis I; Doxiadis G; Fournel C; Rigal D; Monier J C; Grosse-Wilde H
Systemic lupus erythematosus in dogs: association to the major histocompatibility complex class I antigen DLA-A7.
Clinical immunology and immunopathology 1990;55(2):255-62.
-
1990: Doxiadis I; Doxiadis G; Beelen D W; Frenz G; Schaefer U W; Vögeler U; Grosse-Wilde H
Complotyping and subtyping of MHC class I gene products in haplotype determination for bone marrow transplantation.
Haematology and blood transfusion 1990;33():709-11.
-
1990: Schaefer U W; Beelen D W; Graeven U; Kölbel M; Sayer H; Quabeck K; Becher R; Kremens B; Stollmann B; Grosse-Wilde H
Allogeneic and autologous bone marrow transplantation in acute leukemia: the Essen Experience.
Haematology and blood transfusion 1990;33():649-51.
-
1990: Doxiadis I; Dölken P; Schneider M E; Wernet P; Grosse-Wilde H
Heterogeneity in protein patterns of CGL blast crisis cells: discrimination between lymphatic and myeloic lineages.
Haematology and blood transfusion 1990;33():62-6.
-
1990: Doxiadis G; Grosse-Wilde H
C4 allotyping by prolonged gel electrophoresis and immunoblotting using monoclonal and polyclonal antibodies.
Complement and inflammation 1990;7(4-6):269-76.
-
1989: Westhoff U; Doxiadis I; Beelen D W; Schaefer U W; Grosse-Wilde H
Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation.
Transplantation 1989;48(5):891-3.
-
1989: Doxiadis I; Westhoff U; Grosse-Wilde H
Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.
Blut 1989;59(5):449-54.
-
1989: Grosse-Wilde H; Doxiadis I
Allotyping for HLA class I using plasma as antigen source.
Journal of immunogenetics 1989;16(2):149-55.
-
1989: Doxiadis G; Doxiadis I; Frenz G; Vögeler U; Grosse-Wilde H
Relevance of complotyping and subtyping of MHC class I gene products in haplotype definition for allogeneic bone marrow transplantation.
Bone marrow transplantation 1989;4(1):17-22.
-
1989: Doxiadis I; Grosse-Wilde H
Typing for HLA class I gene products using plasma as source.
Vox sanguinis 1989;56(3):196-9.
-
1989: Frenz G; Doxiadis I; Vögeler U; Grosse-Wilde H
HLA class I biochemistry: definition and frequency determination of subtypes by one-dimensional isoelectric focusing and immunoblotting.
Vox sanguinis 1989;56(3):190-5.
-
1989: Doxiadis I; Krumbacher K; Neefjes J J; Ploegh H L; Grosse-Wilde H
Biochemical evidence that the DLA-B locus codes for a class II determinant expressed on all canine peripheral blood lymphocytes.
Experimental and clinical immunogenetics 1989;6(3):219-24.
-
1988: Doxiadis I; Dölken P; Schneider M; Wernet P; Grosse-Wilde H
Heterogeneity in protein patterns of cells from terminal blast crisis in chronic granulocytic leukemia: discrimination between lymphatic and myeloid lineages.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(12 Suppl):57S-62S.
-
1988: Grosse-Wilde H; Kuhn U
[Immunodiagnosis and therapy of habitual abortion]
Der Gynäkologe 1988;21(3):249-61.
-
1988: Beelen D W; Graeven U; Schulz G; Grosse-Wilde H; Doxiadis I; Schaefer U W; Quabeck K; Sayer H; Schmidt C G
Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial.
Onkologie 1988;11(1):56-8.
-
1988: Grosse-Wilde H; Valentine-Thon E; Vögeler U; Passarge E; Lorenzen F; Sippell W G; Bidlingmaier F; Knorr D
HLA-A,B,C,DR typing and 17-OHP determination for second trimester prenatal diagnosis of 21-hydroxylase deficient CAH.
Prenatal diagnosis 1988;8(2):131-43.
-
1987: Beelen D W; Quabeck K; Mahmoud H K; Schaefer U W; Becher R; Schmidt C G; Bamberg M; Quast U; Grosse-Wilde H; Haralambie E
Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.
European journal of cancer & clinical oncology 1987;23(11):1665-71.
-
1987: Grosse-Wilde H; Genth E; Grevesmühl A; Vögeler U; Zarnowski H; Mierau R; Doxiadis G; Doxiadis I; Maas D
HLA-DR4 and Gm 1;21 haplotypes are associated with pseudolupus induced by venopyronum dragées.
Arthritis and rheumatism 1987;30(8):878-83.
-
1987: Bull R W; Vriesendorp H M; Cech R; Grosse-Wilde H; Bijma A M; Ladiges W L; Krumbacher K; Doxiadis I; Ejima H; Templeton J
Joint report of the Third International Workshop of Canine Immunogenetics. II. Analysis of the serological typing of cells.
Transplantation 1987;43(1):154-61.
-
1987: Doxiadis G; Schoen W; Doxiadis I; Deeg H J; O'Neill G J; Grosse-Wilde H
Statement on the nomenclature of dog C4 allotypes.
Immunogenetics 1987;25(3):167-70.
-
1987: Grosse-Wilde H; Doxiadis I; Vögeler U; Mahmoud H K; Schäfer U W; Beelen D W; Ploegh H L
An HLA lost mutation may lead to leukemic relapse of recipient type six years after bone marrow transplantation.
Haematology and blood transfusion 1987;30():571-3.
-
1986: Grosse-Wilde H; Krumbacher K; Schüning F; Doxiadis I; Mahmoud H K; Emde C; Schmidt-Weinmar A; Schaefer U W
Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs.
Transplantation 1986;42(1):64-7.
-
1986: Krumbacher K; van der Feltz M J; Happel M; Gerlach C; Lösslein L K; Grosse-Wilde H
Revised classification of the DLA loci by serological studies.
Tissue antigens 1986;27(5):262-8.
-
1986: Deeg H J; Raff R F; Grosse-Wilde H; Bijma A M; Buurman W A; Doxiadis I; Kolb H J; Krumbacher K; Ladiges W; Losslein K L
Joint report of the Third International Workshop on Canine Immunogenetics. I. Analysis of homozygous typing cells.
Transplantation 1986;41(1):111-7.
-
1985: Doxiadis G; Rebmann V; Doxiadis I; Krumbacher K; Vriesendorp H M; Grosse-Wilde H
Polymorphism of the fourth complement component in the dog.
Immunobiology 1985;169(5):563-9.
-
1985: Mahmoud H K; Ohl S; Schaefer U W; Beelen D; Grosse-Wilde H; Doxiadis I; Richter H J; Schmidt C G
Treatment of hairy-cell leukemia with recombinant leukocyte A interferon.
Onkologie 1985;8(3):141-2.
-
1985: Mahmoud H K; Schaefer U W; Schüning F; Schmidt C G; Grosse-Wilde H; Becher R; Luboldt W
Late relapse of acute nonlymphoblastic leukaemia 6 years following allogeneic bone marrow transplantation.
British journal of haematology 1985;59(4):731-2.
-
1985: Krumbacher K; Happel M; Doxiadis I; Grosse-Wilde H
Enrichment of canine B-lymphocytes by DEGALAN bead columns.
Tissue antigens 1985;25(2):111-4.
-
1985: Doxiadis G; Doxiadis I; Grosse-Wilde H
Polymorphism of human C2 detected by immunoblotting.
Human genetics 1985;70(4):355-8.
-
1984: Mahmoud H K; Schaefer U W; Schüning F; Schmidt C G; Bamberg M; Haralambie E; Linzenmeier G; Hantschke D; Grosse-Wilde H; Luboldt W
Laminar air flow versus barrier nursing in marrow transplant recipients.
Blut 1984;49(5):375-81.
-
1984: Kreeb G; Valentine-Thon E; Krumbacher K; Grosse-Wilde H; Passarge E
HLA-D and -DR antigens on human amniotic fluid cells. II. Heterogeneous expression of HLA-DR and other cell surface markers.
Tissue antigens 1984;23(1):61-7.
-
1983: Grosse-Wilde H; Toyka K V; Besinger U A; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]
Deutsche medizinische Wochenschrift (1946) 1983;108(18):694-700.
-
1983: Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E
HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D.
Tissue antigens 1983;21(2):138-47.
-
1983: Grosse-Wilde H; Doxiadis G; Krumbacher K; Dekkers-Bijma A; Kolb H J
Polymorphism of the fourth complement component in the dog and linkage to the DLA system.
Immunogenetics 1983;18(5):537-40.
-
1983: Höher P G; Vögeler U; Schröder G; Werner J; Doxiadis I; Grosse-Wilde H
Correlation between immunogenetic markers and "in vivo" response to the german hepatitis B vaccine.
Developments in biological standardization 1983;54():171-8.
-
1982: Schaefer U W; Schmidt C G; Rüther U; Schüning F; Becher R; Beyer J H; Hossfeld D K; Nowrousian M R; Ohl S; Wetter O; Bamberg M; Schmitt G; Bormann U; Scherer E; Haralambie E; Linzenmeier G; Grosse-Wilde H; Hierholzer E; Kuwert E; Henneberg K B; Luboldt W; Richter H J; Leder L D; Hantschke D
[Bone marrow transplantation for aplastic anaemia and acute leukaemia (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1982;107(21):803-8.
-
1981: Poser S; Ritter G; Bauer H J; Kuwert E K; Höher P G; Grosse-Wilde H; Hierholzer E
[Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)]
Der Nervenarzt 1981;52(6):326-8.
Sign-in to see more